February 20, 2018 / 7:40 AM / 6 months ago

BRIEF-Rovi Sees 2018 Operating Revenue Growth At Mid-Single-Digit Rate

Feb 20 (Reuters) - Laboratorios Farmaceuticos ROVI SA (ROVI) :

* FOR 2018 SEES A MID-SINGLE-DIGIT GROWTH RATE FOR OPERATING REVENUE WITH A RANGE OF 20 MILLION EURO - 30 MILLION EURO SALES OF ENOXAPARIN BIOSIMILAR‍​

* TO PROPOSE A DIVIDEND OF 0.1207 EUROS PER SHARE FOR FY 2017

* FY EBITDA DOWN 22 PERCENT AT 30.5 MILLION EUROS VERSUS 39.3 MILLION EUROS YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below